Full List of Protein(s) Regulating This Metabolite |
Amino acid/auxin permease (AAAP) |
Sodium-coupled neutral amino acid transporter 9 (SLC38A9) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Truncation of SLC38A9 |
Induced Change |
Valine concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that truncation of SLC38A9 leads to the increase of valine levels compared with control group. |
Solute carrier family 38 member 2 (SLC38A2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Knockdown (siRNA) of SLC38A2 |
Induced Change |
Valine concentration: increase (FC = 1.37) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that knockdown of SLC38A2 leads to the increase of valine levels compared with control group. |
Amino acid/polyamine transporter (AAPT) |
Integral membrane E16 (SLC7A5) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Overexperisson of SLC7A5 |
Induced Change |
Valine concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that co-overexperisson of SLC7A5 and SLC7A8 leads to the decrease of valine levels compared with control group. |
L-type amino acid transporter 2 (LAT2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Overexperisson of SLC7A8 |
Induced Change |
Valine concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that co-overexperisson of SLC7A5 and SLC7A8 leads to the decrease of valine levels compared with control group. |
GPCR rhodopsin (GPCR-1) |
Adrenergic receptor beta-3 (ADRB3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[5] |
Introduced Variation |
Agonist (CL-316,243) of Adrb3 |
Induced Change |
Valine concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that agonist of ADRB3 leads to the increase of valine levels compared with control group. |
GPCR secretin (GPCR-2) |
Glucagon receptor (GCGR) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[6] |
Introduced Variation |
Knockout of Gcgr |
Induced Change |
Valine concentration: increase (FC = 1.3) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Type 2 diabetes mellitus [ICD-11: 5A11]
|
Details |
It is reported that knockout of GCGR leads to the increase of valine levels compared with control group. |
Hydrolases (EC 3) |
Alpha-N-acetylglucosaminidase (NAGLU) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Knockout of Naglu |
Induced Change |
Valine concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Lysosomal storage diseases [ICD-11: 5C56]
|
Details |
It is reported that knockout of Naglu leads to the decrease of valine levels compared with control group. |
GTPase KRas (KRAS) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[8] |
Introduced Variation |
Overexpression of KRAS |
Induced Change |
Valine concentration: decrease (FC = 0.68) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Lung cancer [ICD-11: 2C25]
|
Details |
It is reported that overexpression of KRAS leads to the decrease of valine levels compared with control group. |
Sulfatase sulf-1 (SULF1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] |
Introduced Variation |
Knockdown (shRNA) of SULF1 |
Induced Change |
Valine concentration: decrease (FC = 0.47 / 0.52) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Ovarian cancer [ICD-11: 2C73]
|
Details |
It is reported that knockdown of SULF1 leads to the decrease of valine levels compared with control group. |
Oxidoreductases (EC 1) |
L-2-hydroxyglutarate dehydrogenase (L2HGDH) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[10] |
Introduced Variation |
Mutation (Nonsense mutations or missense mutations) of L2hgdh |
Induced Change |
Valine concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Melanoma [ICD-11: 2C30]
|
Details |
It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of valine levels compared with control group. |
Pore-forming PNC peptide (PNC) |
Cellular tumor antigen p53 (TP53) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[11] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Valine concentration: decrease (Log2 FC=0.89) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of valine levels compared with control group. |
Transcription factor (TF) |
Myc proto-oncogene protein (MYC) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[12] |
Introduced Variation |
Knockdown (siRNA) of MYC |
Induced Change |
Valine concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colorectal cancer [ICD-11: 2B91]
|
Details |
It is reported that knockdown of MYC leads to the decrease of valine levels compared with control group. |
Transcriptional coactivator (TC) |
PPAR-gamma coactivator 1-alpha (PPARGC1A) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[13] |
Introduced Variation |
Overexpression of Ppargc1a |
Induced Change |
Valine concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that overexpression of Ppargc1a leads to the decrease of valine levels compared with control group. |
Transferases (EC 2) |
Acetylglucosaminyltransferase 5 (MGAT5) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[14] |
Introduced Variation |
Knockout of Mgat5 |
Induced Change |
Valine concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that knockout of Mgat5 leads to the increase of valine levels compared with control group. |
Deacetylase sirtuin-5 (SIRT5) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[15] |
Introduced Variation |
Knockout of Sirt5 |
Induced Change |
Valine concentration: increase (FC = 1.17) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that knockout of Sirt5 leads to the increase of valine levels compared with control group. |
Zinc finger protein (ZIN) |
Protein snail homolog 1 (SNAI1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[16] |
Introduced Variation |
Knockdown (shRNA) of SNAI1 |
Induced Change |
Valine concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Breast cancer [ICD-11: 2C60]
|
Details |
It is reported that knockdown of Snai1 leads to the increase of valine levels compared with control group. |
|
|
|
|
|
|
|